Norway vs Portugal: Death rate from Alzheimer's
Norway
86.26 deaths per 100,000 people
in 2021
Portugal
82.46 deaths per 100,000 people
in 2021
Norway rank
7th
Portugal rank
9th
Death rate from Alzheimer's over time
- Norway
- Portugal
How they compare
Norway currently reports 86.26 deaths per 100,000 people against 82.46 deaths per 100,000 people in Portugal, a difference of 3.8 deaths per 100,000 people.
Across all 22 years both countries report, Norway has been ahead every year.
Norway ranks 7th and Portugal ranks 9th of 194 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.6 deaths per 100,000 people | 15.5 deaths per 100,000 people | 22.1 deaths per 100,000 people | Norway |
| 2010s | 67.53 deaths per 100,000 people | 46.01 deaths per 100,000 people | 21.52 deaths per 100,000 people | Norway |
| 2020s | 84.86 deaths per 100,000 people | 82.38 deaths per 100,000 people | 2.48 deaths per 100,000 people | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Norway or Portugal?
- Norway, at 86.26 deaths per 100,000 people against 82.46 deaths per 100,000 people in Portugal as of 2021.
- What is the difference in death rate from alzheimer's between Norway and Portugal?
- 3.8 deaths per 100,000 people, with Norway ahead.
- How many years of comparable data are there for Norway and Portugal?
- 22 years are reported by both, from 2000 to 2021.
- How do Norway and Portugal rank globally for death rate from alzheimer's?
- Norway ranks 7th and Portugal ranks 9th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.